<DOC>
	<DOCNO>NCT00979472</DOCNO>
	<brief_summary>The purpose study compare effect solifenacin succinate frequent micturition patient urgency without urgency .</brief_summary>
	<brief_title>Solifenacin Flexible Dosing Study Frequent Micturition Patients With Without Urgency</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>For withouturgency group : urinary frequency ≥ 8 micturition per 24 hour urgency void diary ( 1 2 5 urgency scale ) For withurgency group : urinary frequency ≥ 8 micturition per 24 hour symptom urinary urgency≥ 2/day void diary ( 3 5 5 urgency scale ) Symptoms last 3 month Clinically significant stress incontinence determine investigator ; female patient , clinically significant stress incontinence confirm cough provocation test Total daily urine volume &gt; 3000 mL verify micturition diary randomization Significant hepatic renal disease , define twice upper limit reference range serum concentration aspartate aminotra Any condition contraindication anticholinergic treatment , include uncontrolled narrowangled glaucoma , urinary retention gastric retention Symptomatic acute urinary tract infection ( UTI ) runin period Recurrent UTIs define treat symptomatic UTIs &gt; 4 time last year Diagnosed suspected interstitial cystitis Uninvestigated hematuria hematuria secondary malignant disease Clinically significant bladder outlet obstruction define clinical symptom investigator 's opinion accord local standard care ( residual urine &gt; 100mL functional bladder capacity ) Patients mark cystocele clinically significant pelvic prolapse Treatment within 14 day precede randomization , expect initiate treatment study : Any anticholinergic drug randomize trial drug Any drug treatment overactive bladder . Estrogen treatment start 2 month prior inclusion allow On unstable dosage drug anticholinergic side effect , expect start treatment study Receipt electrostimulation bladder training within 14 day randomization , expect start treatment study An indwelling catheter practice intermittent selfcatheterization Use investigational drug within 1 month prior start study Patients chronic constipation history severe constipation Pregnant nursing woman Sexually active female childbearing potential use reliable contraception least 1 month prior start study agree use method entire study period least 1 month thereafter . Reliable contraceptive method define intrauterine device ( IUDs ) , combination type contraceptive pill , hormonal implant , double barrier method , injectable contraceptive surgical procedure ( tubal ligation vasectomy ) Patients bladder cancer prostate cancer Treatment potent CYP3A4 inhibitor , cyclosporine , vinblastine , macrolide antibiotic ( e.g . erythromycin , clarithromycin , azithromycin ) antifungal agent ( e.g . ketoconazole , itraconazole , micronazole ) Patients neurological disease Patients psychological disease Any condition , opinion investigator , make patient unsuitable inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>Overactive bladder</keyword>
	<keyword>Micturition</keyword>
	<keyword>Urinary urgency</keyword>
	<keyword>Vesicare</keyword>
</DOC>